Magnendo develops AI-powered endoscopy and robotics technologies for gastrointestinal disease detection, diagnosis, and clinical support.
Magnendo has raised $18.0M in total funding. The most recent round was Series A. The last funding was announced in July 2026.
Magnendo's investors include Kakao Ventures, Penumbra, Bass Investment, SBXi.
Magnendo is headquartered in Newton, United States.
Magnendo develops AI-powered endoscopy and robotics technologies for gastrointestinal disease detection, diagnosis, and clinical support.
Magnendo is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Magnendo — Funding & Investors." VCBacked, July 24, 2026, https://www.vcbacked.co/company/magnendo. Accessed September 13, 2026.
VCBacked. (2026). Magnendo — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/magnendo
{{cite web |title=Magnendo — Funding & Investors |url=https://www.vcbacked.co/company/magnendo |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated